Mon, August 15, 2022

Swayampakula Ramakanth Maintained (CASI) at Strong Buy with Increased Target to $12 on, Aug 15th, 2022

Swayampakula Ramakanth of HC Wainwright & Co., Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Increased Target from $3 to $12 on, Aug 15th, 2022.

Swayampakula has made no other calls on CASI in the last 4 months.



There are 2 other peers that have a rating on CASI. Out of the 2 peers that are also analyzing CASI, 0 agree with Swayampakula's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Swayampakula


  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $21 on, Friday, June 3rd, 2022
  • Sean Lee of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $30 on, Monday, May 16th, 2022